Wed, May 27, 2020
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Insurers reduce hedge fund exposure

Friday, May 22, 2020

Bailey McCann, Opalesque New York:

For a fourth straight year, the U.S. insurance industry reduced its hedge fund investments. Insurers pulled out $2.6 billion in 2019, bringing total exposure to $11.9 billion, according to new research from AM Best.

The continued pullback leaves the property/casualty insurance segment with $6.3 billion of hedge fund investments. The life/annuity segment (L/A) saw a fourth straight year of reductions, cutting back by 11.9% in 2019 to $5.1 billion. The health segment's holdings also ticked down by roughly $100 million to approximately $490 million; however, hedge fund holdings are concentrated, as fewer than a dozen health insurers invest in this asset class. The report notes that the 2019 declines occurred despite the hedge fund industry posting a return of more than 11%, just the second time industry returns have exceeded double digits in the last six years.

"Many insurers continue to say they are not getting the returns needed for the fees and capital requirements costing them in the current environment," says Jason Hopper, associate director, industry research and analytics, AM Best Rating Services.

Insurers weren't the only institutions cutting back on hedge fund allocations in 2019. Investors pulled more than $97 billion out of hedge funds last year citing performance and fee concerns. Insurers primarily cut allocations to long/short equity hedge funds and multi-strategy funds.

Larger insurers were more likely to......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Tiger Global tops the list US-based venture capital market[more]

    Laxman Pai, Opalesque Asia: Tiger Global Management holds on to its position as market-leader in US-based venture capital, said a study. According to Preqin, the closure of tech-focused Tiger Global Private Investment Partners XII in January means the New York-based firm has raised more than

  2. Tech: Fintech startup Brex closes $150m in pure venture funding amid recession[more]

    From Business Insider: Brex, the 3-year-old fintech unicorn, raised an additional $150 million in equity funding from existing investors and Lone Pine Capital, the company announced Tuesday. The cash infusion raised the startup's valuation to "around the $3 billion mark," cofounder and co-CEO Henriq

  3. PE/VC: Venture debt set to take prominent role, Building out Goldman Sachs's private-equity business[more]

    Venture debt set to take prominent role From PE News: Venture debt financing could be having its moment as the equity market becomes less friendly to start-ups. About $10bn worth of venture debt deals were made this year as of 21 April, a pace set to eclipse the roughly $25bn in such de

  4. Study: Emerging market bond issuers take hit as global recession deepens, The coronavirus pandemic could cost the global economy a nightmarish $82tn over 5 years, a Cambridge study warns[more]

    Emerging market bond issuers take hit as global recession deepens Increasing credit stress evident amongst many high-yield EM non-financial corporates as coronavirus disruption takes its toll, says Moody's. 74 out of 106 rated EM sovereigns have a stable outlook as of 30 April 2020 (compa

  5. Investing: Singer bets on Europe, emerging markets, Britain's unhealthy appetite for financial risk in essential services, How Stan Druckenmiller shook up his portfolio[more]

    Singer bets on Europe, emerging markets From Investment Magazine: William Blair's Brian Singer is looking to invest in Europe and the emerging markets as the recovery from the global economic shutdown to contain the pandemic will likely take longer than what the market has priced in.